Cleared Traditional

K062211 - BIOPLEX 2200 EBV IGG PANEL FOR BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM (FDA 510(k) Clearance)

Dec 2006
Decision
129d
Days
Class 1
Risk

K062211 is an FDA 510(k) clearance for the BIOPLEX 2200 EBV IGG PANEL FOR BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM. This device is classified as a Epstein-barr Virus, Other (Class I - General Controls, product code LSE).

Submitted by Bio-Rad Laboratories, Inc. (Redmond, US). The FDA issued a Cleared decision on December 8, 2006, 129 days after receiving the submission on August 1, 2006.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K062211 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2006
Decision Date December 08, 2006
Days to Decision 129 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LSE — Epstein-barr Virus, Other
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235